Press Release: SAW Components Global Markets Report 2026: Products, End-Users, Applications and Competition 2024-2030 with 2025 as the Base Year

Glasgow, Scotland – 29 April 2026. EnteroBiotix Limited (‘EnteroBiotix’), a biopharmaceutical company developing best-in-class microbiome therapies for gut health, today announces the completion of a £19m ($25m) financing to advance its lead candidate, EBX-102-02, a next-generation orally delivered full-spectrum investigational microbiome therapeutic, into Phase 2b development for Irritable Bowel Syndrome with Constipation (IBS-C).

Key Facts (At-a-Glance): NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Notified today introduced its AI Press Release Optimizer, a purpose-built tool within Content OS that helps communications teams improve large language model (LLM) visibility and strengthen clarity for journalists via AI-powered recommendations.

NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sezzle Inc. (“Sezzle” or the “Company”) (NASDAQ: SEZL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

LOS ANGELES, April 28, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises SES AI Corporation, (“SES” or the "Company") (NYSE: SES) investors of a class action on behalf of investors that bought securities between January 29, 2025 and March 4, 2026, inclusive (the “Class Period”). SES investors have until June 26, 2026 to file a lead…